CCN5 and breast carcinoma: Subsequently, one study confirmed that WISP2 expression can be modulated by serum and is correlated with serum-induced cell growth in breast cancer cells, demonstrating that WISP2 is responsible for serum stimulation and enhances cell growth in breast cancer [15].